ReviewCellular oncology (Dordrecht, Netherlands)2020

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance.

Claudio D'Amore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.